Clinical Trial Update: Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study [Phase 3]

View source ↗

Summary

A Phase 3 pivotal efficacy study for a Travelers' Diarrhea vaccine sponsored by Intercell USA, Inc. has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Travelers Diarrhea

Drugs mentioned

• Travelers' Diarrhea Vaccine

Snippet

Sponsor: Intercell USA, Inc. | Conditions: Travelers' Diarrhea | Phase 3 | Status: COMPLETED